BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27681076)

  • 1. Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung.
    Takamochi K; Ohmiya H; Itoh M; Mogushi K; Saito T; Hara K; Mitani K; Kogo Y; Yamanaka Y; Kawai J; Hayashizaki Y; Oh S; Suzuki K; Kawaji H
    BMC Cancer; 2016 Sep; 16(1):760. PubMed ID: 27681076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
    Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
    J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
    Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
    Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of clinical characteristics and differential diagnosis of the lung biopsy specimens in 99 adenocarcinoma cases and 111 squamous cell carcinoma cases: utility of an immunohistochemical panel containing CK5/6, CK34βE12, p63, CK7 and TTF-1.
    Xu XY; Yang GY; Yang JH; Li J
    Pathol Res Pract; 2014 Oct; 210(10):680-5. PubMed ID: 25063315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers.
    Zachara-Szczakowski S; Verdun T; Churg A
    Hum Pathol; 2015 May; 46(5):776-82. PubMed ID: 25776027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diagnostic and Prognostic Roles of Combined Expression of Novel Biomarkers in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: An Immunohistochemical Study.
    Alabiad MA; Harb OA; Abozaid M; Embaby A; Mandour D; Hemeda R; Shalaby AM
    Iran J Pathol; 2021; 16(2):162-173. PubMed ID: 33936227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.
    Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J
    Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
    Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN
    Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the diagnostic difference between the clinical diagnostic criteria and results of immunohistochemical staining of multiple primary lung cancers.
    Nonami Y; Ohtuki Y; Sasaguri S
    J Cardiovasc Surg (Torino); 2003 Oct; 44(5):661-5. PubMed ID: 14735056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of IGF1R expression in non-small-cell lung cancer.
    Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F
    Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung.
    Kai Y; Amatya VJ; Kushitani K; Kambara T; Suzuki R; Fujii Y; Tsutani Y; Miyata Y; Okada M; Takeshima Y
    Transl Lung Cancer Res; 2021 Feb; 10(2):766-775. PubMed ID: 33718020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
    Noh S; Shim H
    Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
    Agackiran Y; Ozcan A; Akyurek N; Memis L; Findik G; Kaya S
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):350-5. PubMed ID: 22495379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare.
    Zhao W; Choi YL; Song JY; Zhu Y; Xu Q; Zhang F; Jiang L; Cheng J; Zheng G; Mao M
    Lung Cancer; 2016 Apr; 94():22-7. PubMed ID: 26973202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
    Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma.
    Li H; Jiang Z; Leng Q; Bai F; Wang J; Ding X; Li Y; Zhang X; Fang H; Yfantis HG; Xing L; Jiang F
    Oncotarget; 2017 Aug; 8(31):50704-50714. PubMed ID: 28881596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility and pattern of positivity of p40 in the diagnosis of squamous cell carcinoma of the lung by cytology: the first study on fine needle aspiration smears.
    Jain D; Mathur SR; Guleria R; Iyer VK
    Cytopathology; 2014 Oct; 25(5):330-5. PubMed ID: 24128123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined high-grade neuroendocrine carcinoma of the lung: clinicopathological and immunohistochemical study of 34 surgically resected cases.
    Yamada K; Maeshima AM; Tsuta K; Tsuda H
    Pathol Int; 2014 Jan; 64(1):28-33. PubMed ID: 24471967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.